BSP Pharmaceuticals
Latina, IT
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (10)
○ MHRA GMP
Quick Facts: BSP Pharmaceuticals
- Signal Score
- 78.1/100 (as of 2026-04-02)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Latina, IT
- Modalities
- Biologics, mRNA
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates10 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Latina, IT
Modalities: Biologics, mRNA
Capacity assessment: 58.0/100
Sites: Latina, IT
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Latina, IT
Modalities: Biologics, mRNA
Capacity assessment: 58.0/100
EMA GMP Compliance 10 certificates
2025-02
2024-10
2024-10
2024-10
2024-10
2022-05
2022-05
2021-11
2019-11
2019-11
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/42/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2025-02-21 | COMPLIANT |
| IT-API/12/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/25/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/83/H/2025 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/10/H/2026 | Bsp Pharmaceuticals S.p.A. | Italy | 2024-10-11 | COMPLIANT |
| IT-API/7/H/2023 | Bsp Pharmaceuticals S.p.A. | Italy | 2022-05-27 | COMPLIANT |
| IT-API/72/H/2024 | Bsp Pharmaceuticals S.p.A. | Italy | 2022-05-27 | COMPLIANT |
| IT-API/79/H/2022 | Bsp Pharmaceuticals S.p.A. | Italy | 2021-11-12 | COMPLIANT |
| IT-API/107/H/2021 | BSP PHARMACEUTICALS S.P.A. | Italy | 2019-11-22 | COMPLIANT |
| IT-API/54/H/2021 | BSP PHARMACEUTICALS S.P.A. | Italy | 2019-11-22 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 81.6
mRNA, Oligonucleotide, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 81.6
mRNA, Plasmid, Biologics
Evonik Health Care
Birmingham, AL · Vancouver, BC
Signal Score: 81.5
mRNA, Biologics